Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by CentreIce24on Jun 15, 2023 11:25am
144 Views
Post# 35498113

HEXO's accumulated losses crossed the $2 BILLION mark

HEXO's accumulated losses crossed the $2 BILLION markHEXO's accumulated losses crossed the $2 BILLION mark
By revenue stream in Q3 compared to last year:
—Rec sales: $26.5 million (
46%)
—Medical: $647,000 (
28%)
—Int'l: $649,000 (
90%)
—Wholesale: $4 million (up 22%)
—Bevs: $0 (
100%)
Q3 net loss was $117 million.

Cash and/or Cash equivalents of approx $20M as of April 30th
You guys do the math
Without Tilray throwing HEXO a life boat they would have been filing for creditor protection before the end of 2023 if not before

Fingers crossed and hope it works out but still a crazy insane amount to pay in the current market

GLTA
Cheers
<< Previous
Bullboard Posts
Next >>